SlideShare a Scribd company logo
Recent Advances in Diagnosis &
Management of SLE
Speaker- Dr. Shadab Ahmad
Definition
Systemic lupus erythematosus (SLE) is an autoimmune disease in which
organs and cells undergo damage mediated by tissue binding
autoantibodies and immune complexes.
• 90 % of patients at diagnosis are women of childbearing age groups.
• Highest prevalence is in black women and lowest is in white men.
Risk factors
• Female sex
• Black ethnic groups
• Exposure to UV light
• Epstein-Barr virus (EBV) infection
• Tobacco smoking
• Prolonged occupational exposure to silica
Female sex is permissive for SLE because
• Hormone effects
• Genes on X- chromosome
• Epigenetic differences between genders
• Estradiol binds to receptors on T and B lymphocytes, increasing
activation and survival of those cells, thus favoring prolonged immune
response.
• So, women exposed to estrogen containing OCPs and hormone
replacement therapy have an increased risk of developing SLE.
• People with more X- chromosome (XXY karyotype, Klinefelter’s
syndrome) have a significantly increased risk for SLE.
Pathogenesis
Autoantibodies in SLE
Antibodies Antigen Recognized
ANA Multiple nuclear antigens
Anti-dsDNA dsDNA
Anti-Sm Protein complexed to 6 species of nuclear U1 RNA
Anti-RNP Protein complexed to U1 RNA-gamma
Anti-Ro (SS-A) Protein complexed to hY RNA (60 kDa, 52 kDa)
Anti La (SS-B) Protein complexed to hY RNA (47 kDa)
Anti-histone Histone associated with DNA(in nucleosome, chromatin)
Antiphospholipid Phospholipids, beta-2 glycoprotein 1 cofactor,
prothrombin
Antierythrocyte Erythrocyte membrane
Antiplatelet Surface and altered cytoplasmic antigens on platelets
Antineuronal (anti-glutamate receptors) Neuronal and lymphocyte surface antigens
Antiribosomal P Protein on ribosomes
New Antibodies
Antibodies Used as marker of Role in SLE
Anti-nucleosome antibodies Disease activity and organ
involvement
Drug induced lupus, lupus
nephritis, lupus flares
Anti-C-1q antibodies Disease activity and organ
involvement
Nephritic flares
NMDA receptor antibody Neuronal damage Neuropsychiatric disease
Anti-Alpha actinin antibody Disease activity, renal involvement Lupus nephritis
Diagnosis of SLE
1. ACR criteria
2. SLICC criteria
ACR Criteria
Malar rash Fixed erythema, flat or raised, over malar eminence
Discoid rash Erythematous circular raised patches with adherent keratotic scaling and follicular
plugging; atrophic scarring may occur
Photosensitivity Exposure to ultraviolet light causes rashes
Oral ulcers Includes oral and nasopharyngeal ulcers, observed by physician
Arthritis Nonerosive arthritis of two or more peripheral joints, with tenderness, swelling, or
effusion
Serositis Pleuritis or pericarditis documented by ECG or rub or evidence of effusion
Renal disorder Proteinuria >0.5 g/d or 3+, or cellular casts
Neurologic disorder Seizures or psychosis without other causes
Hematologic disorders Hemolytic anemia or leukopenia (<4000/dl) or lymphopenia (<1500/dl) or
thrombocytopenia (<1,00,000/dl) in absence of offendidng drugs
Immunologic disorder Anti-dsDNA, anti-Sm, and/or anti-phospholipid
Antinuclear antibodies An abnormal titer of ANA by immunofluorescence or an equivalent assay at any point
in time in the absence of drugs known to induce ANAs
Sensitivity is – 75%
Specificity is – 95%
SLICC criteria
(Systemic Lupus International Collaborating Clinics Classification 2012 )
Clinical Criteria
Acute Cutaneous lupus Lupus malar rash, bullous lupus, toxic epidermal necrolysis variant of SLE, maculopapular lupus
rash, photosensitivity lupus rash (in absence of dermatomyositis)
Chronic Cutaneous lupus Classic discoid rash localized (above the neck) or generalized (above and below neck),
hypertrophic (verrucous) lupus, lupus panniculitis (profundus), mucosal lupus, chilblains lupus,
discoid lupus/lichen planus overlap
Oral Ulcers or Nasal
Ulcers
Oral: palate, buccal, tongue, nasal ulcers. In the absence of other causes, such as vasculitis,
Behcet’s disease, infection, inflammatory bowel disease, reactive arthritis, and acidic foods
Non-scarring alopecia Diffuse thinning or hair fragility with visible broken hairs, in the absence of other causes such as
alopecia areata, drugs, iron deficiency, and androgenic alopecia
Synovitis involving 2 or
more joints
Characterized by swelling or effusion or tenderness in 2 or more joints and at least 30 minutes
of morning stiffness
Serositis Typical pleurisy for more than 1 day or pleural effusion or pleural rub. Typical pericardial pain
(pain with recumbency improved by sitting forward) for more than 1 day or pericardial effusion
or pericardial rub or pericarditis by electrocardiography
SLICC criteria cont…
Clinical Criteria cont..
Renal Urine protein to creatinine ratio (or 24 hour urine protein) representing 500 mg protein/24
hour or red blood cell casts.
Neurologic Seizure, psychosis, mononeuritis multiplex (in the absence of other known causes such
primary vasculitis), myelitis, peripheral or cranial neuropathy (in the absence of other
known causes such as primary vasculitis, infection, and diabetes mellitus), acute confusional
state (in the absence of other causes, including toxic/metabolic, uremia, drugs)
Hemolytic anemia
Leukopenia (<4000/mm3) OR At least once: In the absence of other causes such as Felty’s syndrome, drugs, and portal
hypertension
Lymphopenia (<1000/mm3) At least once: In the absence of other known causes such as corticosteroids, drugs, and
infection
Thrombocytopenia
(<100,000/mm3)
At least once in the absence of other known causes such as drugs, portal hypertension, and
thrombotic thrombocytopenic purpura
SLICC criteria cont…
Immunologic
Criteria
ANA Level above laboratory reference range
Anti-dsDNA Antibody level above laboratory reference range (or 2-fold if tested by ELISA)
Anti-Sm Presence of antibody to Sm nuclear antigen
Anti-phospholipid
antibody
Positivity, as determined by
Positive test for lupus anticoagulant
False-positive test result for rapid plasma regain
Medium-or high titer anticardiolipin antibody level (IgA, IgG, or IgM)
Positive test result for anti-2-glycoprotein I (IgA, IgG, or IgM)
Low complement (C3, C4, or CH50)
Direct Coomb’s
test
(In the absence of hemolytic anemia)
Sensitivity is – 94%
Specificity is – 92%
Classify a patient as having SLE if..
ACR criteria
 If ≥4 of these criteria, well documented, are present at any time in a
patient’s history
SLICC criteria
 The patient satisfies four of the criteria including at least one clinical
criterion and one immunologic criterion
OR
 The patient has biopsy proven nephritis compatible with SLE and
with ANA or anti-dsDNA antibodies
Novel Biomarkers in SLE
Cellular markers Used as marker of Role in SLE
CD27 plasma cells Disease activity Distinguish a lupus flare up from infection
CD44v3/CD44v6-T cells Disease activity Lupus nephritis
CD4- CD8- (double
negative) t cells
Disease activity Lupus nephritis
Plasma MBL Disease activity Lupus nephritis (high level), Cutaneous lupus (low level)
Complement activation
products
Diagnosis or disease
activity
Diagnosis of SLE
Cytokines
IFN-𝛼, IFN-𝛾 Disease activity/flare Marker and potential predictive marker for anti-type I IFN therapy
MCP-1 Disease activity/flare
IL-2, IL-6, IL-10, IL-17, IL-23
TNF-𝛼, IFN-𝛼, TGF-B
Disease activity Diagnosis and progression of SLE
TWEAK Disease activity Lupus nephritis
Novel Biomarkers cont..
Genomic markers Used as marker of Role in SLE
Fc receptor gene polymorphism Disease susceptibility Diagnosis of SLE
DNA methylation markers (CD70,
CD154, Perforin)
Disease activity Diagnosis and monitoring
Micro RNAs Disease activity and effect of
treatment
Monitoring of SLE
New gene therapy strategies
Therapeutic classification
Mild Moderate
Muco-cutaneous
Butterfly rash
Photosensitivity
Maculopapular rash
Mild oral ulcer
Mild DLE
Severe oral ulcer
Severe DLE
Diffuse SCLE
Lupus profundus
Skin vasculitis
Articular Arthralgia
Mild polyarthritis
Disabiling polyarthritis
Cont…
Mild Moderate Severe
Renal Class I,II Class III,IV
LN
Neuropsychiatry Lupus headache Chorea
Peripheral neuropathy
Delirium
Encephalitis
Psychosis
Coma
Myelopathy
Hematological Platelet 30-100,000 Platelet 15-30,000
Hemolytic anemia
Leucopenia
Lupus adenitis
Platelet <15,000
Cont…
Mild Moderate Severe
Cardiopulmonary Pleurisy Pleural effusion
Pneumonitis
Pericarditis
Mild myocarditis
Severe pneumonitis with
respiratory failure
Pulmonary hemorrhage
Cardiac temponade
Severe myocarditis
Gastro-intestinal Mild hepatitis Pancreatitis
Peritonitis
Severe hepatitis
Colitis
Protein losing
enteropathy
Mesenteric vasculitis
Miscellaneous Responsive fever
Fatigue
Myalgia
Refractory/high fever
Treatment of SLE
Conventional therapies
• NSAIDs
• Anti-malarials
• Corticosteroids
• Immunosupressants
Targeted therapies
• Monoclonal antibodies
Drugs for management of SLE
Medication Dose range Adverse effects
NSAISs Upper limit of recommended
range
Aseptic meningitis, decreased renal function, vasculitis of skin,
myocardial infarction, ototoxicity, GI irritation
Topical glucocorticoids Mid potency for face
High potency- other area
Atrophy of skin, contact dermatitis, folliculitis, infection,
hypopigmentation
Topical sunscreens SPF 15 at least
30+ preferred
Contact dermatitis
Hydroxychloroquine 200-400 mg OD Retinal damage, agranulocytosis, thrombocytopenia, aplastic
anemia, ataxia, cardiomyopathy, ototoxicity, neuropathy, seizures
DHEA
(dehydrepiandrosterone)
200 mg OD Acne, menstrual irregularity
Methotrexate 10-25 mg once a week with
folic acid
Anemia, bone marrow suppression, leukopenia, infection,
thrombocytopenia, hepatotoxicity, nephrotoxicity, neurotoxicity,
pulmonary fibrosis, pneumonitis, teratogenic
Oral glucocorticoids
(Prednisone)
0.5-1 mg/kg/d- severe SLE
0.07-0.3 mg/kg/d- milder SLE
Infection, hypertension, hyperglycemia, hypokalemia, aseptic
necrosis of bone, cushingoid changes, osteoporosis, psychosis
IV glucocorticoids
(Methylprednisolone)
1 g *IV*OD for 3 days As oral glucocorticoids
Cont…
Medication Dose range Adverse effects
Cyclophosphamide 7-25 mg/kg once a month
for 6 months
Infection, bone marrow suppression, leukopenia, anemia,
thrombocytopenia, hemorrhagic cystitis, carcinoma bladder,
alopecia, ovarian and testicular failure, teratogenic
Mycophenolate
mofetil
2-3 g/d Infection, leukopenia, anemia, thrombocytopenia, lymphoma,
malignancy, alopecia, GI symptoms, hypertension,
hypokalemia, tremor, teratogenic
Azathioprine 2-3 mg/kg/d Infection, bone marrow suppression, leukopenia, anemia,
thrombocytopenia, pancreatitis, hepatotoxicity, malignancy,
alopecia, GI symptoms
Targeted therapy in SLE
Target Agent Role in SLE
B Cell depletion
Anti-CD20 Rituximab Effective in refractory SLE, no benefit in proliferative lupus
nephritis
Anti-CD22 Epratuzumab Reduction in corticosteroid dose in SLE
Anti-CD11 Efalizumab Improvement in cutaneous SLE
B Cell activation
Anti-B Lys Antibody Belimumab Reduction in SLE activity, reduce flares
Anti-B Lys+APRIL Atacicept Decrease in SLE autoantibodies
B Cell tolerogens
B cell tolerogen Abetimus,
Edratide
No long term benefit in lupus nephritis
T-Cell target blockers
Anti-CD40 antibodies Toralizumab Unproven role
CTLA4-Ig Fusion protein Abatacept Improvement in non-life threatening SLE
Cell surface receptor
activation inhibition
Sirolimus Role in refractory SLE
Cont…
Target Agent Role in SLE
Cytokine inhibition
Anti-TNF-𝛼 Infliximab Doubtful efficacy in lupus nephritis
Anti-IFN-𝛼/-𝛾 Sifalimumab
Rontalizumab
No result released
Anti-IL-1 Anakinra Improvement in SLE arthritis
Anti-IL-6 Tocilizumab Clinical and serologic improvements in SLE
Anti-IL-10 B-N10 Improvement in disease activity
Other targets
Anti-C5 monoclonal
antibody
Eculizumab Improvement in SLE
Soluble recombinant
complement C3
inhibitor
sCR1 Improvement in disease activity
Chemokine inhibitor Bindarit Improvement in disease activity
Diagnosis & Initial therapy of SLE
THANK YOU

More Related Content

What's hot

Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Prof Dr Bashir Ahmed Dar
 
Atypical pneumonia
Atypical pneumoniaAtypical pneumonia
Atypical pneumonia
Marwa Khalifa
 
5 Hemorrhagic Fever With Renal Syndrome
5 Hemorrhagic Fever With Renal Syndrome5 Hemorrhagic Fever With Renal Syndrome
5 Hemorrhagic Fever With Renal SyndromeSumit Prajapati
 
Malaria - Complications (Severe Malaria)
Malaria - Complications (Severe Malaria)Malaria - Complications (Severe Malaria)
Malaria - Complications (Severe Malaria)
Brij Bhushan
 
Acute Respiratory Insufficiency(ARI)
Acute Respiratory Insufficiency(ARI)Acute Respiratory Insufficiency(ARI)
Acute Respiratory Insufficiency(ARI)
Eneutron
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
Singaram_Paed
 
Tularemia
TularemiaTularemia
Tularemia
drnishant21
 
Pseudotuberculosis
PseudotuberculosisPseudotuberculosis
Pseudotuberculosis
Ladi Anudeep
 
Fever of Unknown Origin (FUO)
Fever of Unknown Origin (FUO)Fever of Unknown Origin (FUO)
Fever of Unknown Origin (FUO)
Dr. Juan Carlos Becerra Martinez
 
Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB ) Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB )
MOHAMMAD NOUR AL SAEED
 
Acute Intestinal Infections in Children
Acute Intestinal Infections in ChildrenAcute Intestinal Infections in Children
Acute Intestinal Infections in Children
Eneutron
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
Aswin Rm
 
Malaria Parasite
Malaria ParasiteMalaria Parasite
Malaria Parasite
VENCIOUS_25-2013
 
Meningococci
MeningococciMeningococci
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
Jaskaran Sandhu
 
Antiphospholipid Antibody syndrome- Updated Guidelines
Antiphospholipid Antibody syndrome- Updated GuidelinesAntiphospholipid Antibody syndrome- Updated Guidelines
Antiphospholipid Antibody syndrome- Updated GuidelinesSuneth Weerarathna
 
Non typhoid salmonellosis
Non typhoid salmonellosisNon typhoid salmonellosis

What's hot (20)

Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
 
Atypical pneumonia
Atypical pneumoniaAtypical pneumonia
Atypical pneumonia
 
5 Hemorrhagic Fever With Renal Syndrome
5 Hemorrhagic Fever With Renal Syndrome5 Hemorrhagic Fever With Renal Syndrome
5 Hemorrhagic Fever With Renal Syndrome
 
Malaria - Complications (Severe Malaria)
Malaria - Complications (Severe Malaria)Malaria - Complications (Severe Malaria)
Malaria - Complications (Severe Malaria)
 
Acute Respiratory Insufficiency(ARI)
Acute Respiratory Insufficiency(ARI)Acute Respiratory Insufficiency(ARI)
Acute Respiratory Insufficiency(ARI)
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
 
Tularemia
TularemiaTularemia
Tularemia
 
Pseudotuberculosis
PseudotuberculosisPseudotuberculosis
Pseudotuberculosis
 
Fever of Unknown Origin (FUO)
Fever of Unknown Origin (FUO)Fever of Unknown Origin (FUO)
Fever of Unknown Origin (FUO)
 
Strongyloides schistosoma
Strongyloides schistosomaStrongyloides schistosoma
Strongyloides schistosoma
 
Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB ) Cutaneous tuberculosis ( SKIN TB )
Cutaneous tuberculosis ( SKIN TB )
 
Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)Bhuwan (rickettsial disease)
Bhuwan (rickettsial disease)
 
Acute Intestinal Infections in Children
Acute Intestinal Infections in ChildrenAcute Intestinal Infections in Children
Acute Intestinal Infections in Children
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Human Bartonellosis
Human BartonellosisHuman Bartonellosis
Human Bartonellosis
 
Malaria Parasite
Malaria ParasiteMalaria Parasite
Malaria Parasite
 
Meningococci
MeningococciMeningococci
Meningococci
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
 
Antiphospholipid Antibody syndrome- Updated Guidelines
Antiphospholipid Antibody syndrome- Updated GuidelinesAntiphospholipid Antibody syndrome- Updated Guidelines
Antiphospholipid Antibody syndrome- Updated Guidelines
 
Non typhoid salmonellosis
Non typhoid salmonellosisNon typhoid salmonellosis
Non typhoid salmonellosis
 

Similar to Recent advances in diagnosis &amp; management of SLE

lupus nephritis
lupus nephritislupus nephritis
lupus nephritisKushal Dp
 
Systemic lupus erythematosis
Systemic lupus erythematosisSystemic lupus erythematosis
Systemic lupus erythematosis
Ranjithkumar Kondapaka
 
SLE.pptx
SLE.pptxSLE.pptx
SLE.pptx
Minella4
 
Systemic Lupus Erythematoses
Systemic Lupus ErythematosesSystemic Lupus Erythematoses
Systemic Lupus Erythematoses
drangelosmith
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus ErythematosusSheelendra Shakya
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus ErythematosusDr Raj Thorat
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
rod prasad
 
Sle diagnosis &amp; treatment
Sle diagnosis &amp; treatmentSle diagnosis &amp; treatment
Sle diagnosis &amp; treatment
DrSuman Roy
 
Systemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki diseaseSystemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki disease
Tai Alakawy
 
SYSTEMIC LUPUS ERYTHEMATOSUS.pptx
SYSTEMIC LUPUS ERYTHEMATOSUS.pptxSYSTEMIC LUPUS ERYTHEMATOSUS.pptx
SYSTEMIC LUPUS ERYTHEMATOSUS.pptx
A7mdM7moOd
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
Kirsha K S
 
Sle by dr. tarun betha
Sle by dr. tarun bethaSle by dr. tarun betha
Sle by dr. tarun betha
Tarun Prudvi Betha
 
Systemic Lupus-erythmatosus a detailed review.pdf
Systemic Lupus-erythmatosus  a detailed review.pdfSystemic Lupus-erythmatosus  a detailed review.pdf
Systemic Lupus-erythmatosus a detailed review.pdf
UsamaSaleem91
 
Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus
LupusNY
 
SLE and its Associated Disorders
SLE and its Associated DisordersSLE and its Associated Disorders
SLE and its Associated Disorders
Rafiqul Islam
 

Similar to Recent advances in diagnosis &amp; management of SLE (20)

lupus nephritis
lupus nephritislupus nephritis
lupus nephritis
 
Systemic lupus erythematosis
Systemic lupus erythematosisSystemic lupus erythematosis
Systemic lupus erythematosis
 
SLE.pptx
SLE.pptxSLE.pptx
SLE.pptx
 
Systemic Lupus Erythematoses
Systemic Lupus ErythematosesSystemic Lupus Erythematoses
Systemic Lupus Erythematoses
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Systemic lupus erythematosus overview
Systemic lupus erythematosus   overviewSystemic lupus erythematosus   overview
Systemic lupus erythematosus overview
 
Sle diagnosis &amp; treatment
Sle diagnosis &amp; treatmentSle diagnosis &amp; treatment
Sle diagnosis &amp; treatment
 
Systemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki diseaseSystemic lupus erythematosis & Kawasaki disease
Systemic lupus erythematosis & Kawasaki disease
 
Lupus nephritis post fff
Lupus nephritis  post fffLupus nephritis  post fff
Lupus nephritis post fff
 
SYSTEMIC LUPUS ERYTHEMATOSUS.pptx
SYSTEMIC LUPUS ERYTHEMATOSUS.pptxSYSTEMIC LUPUS ERYTHEMATOSUS.pptx
SYSTEMIC LUPUS ERYTHEMATOSUS.pptx
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
 
Sle by dr. tarun betha
Sle by dr. tarun bethaSle by dr. tarun betha
Sle by dr. tarun betha
 
Systemic Lupus-erythmatosus a detailed review.pdf
Systemic Lupus-erythmatosus  a detailed review.pdfSystemic Lupus-erythmatosus  a detailed review.pdf
Systemic Lupus-erythmatosus a detailed review.pdf
 
Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus Get Into the Loop - Learn About Lupus
Get Into the Loop - Learn About Lupus
 
Sle by dr qudsia
Sle by dr qudsiaSle by dr qudsia
Sle by dr qudsia
 
SLE Presentation
SLE PresentationSLE Presentation
SLE Presentation
 
Sle presentation
Sle presentationSle presentation
Sle presentation
 
SLE and its Associated Disorders
SLE and its Associated DisordersSLE and its Associated Disorders
SLE and its Associated Disorders
 

More from Shadab Ahmad

Stemi
StemiStemi
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
Shadab Ahmad
 
Post pci management of acs
Post pci management of acsPost pci management of acs
Post pci management of acs
Shadab Ahmad
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
Shadab Ahmad
 
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Shadab Ahmad
 
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Underg...
Residual Inflammatory Risk inPatients With Low LDL CholesterolLevels Underg...Residual Inflammatory Risk inPatients With Low LDL CholesterolLevels Underg...
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Underg...
Shadab Ahmad
 
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Shadab Ahmad
 
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Shadab Ahmad
 
Percutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve ReplacementPercutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve Replacement
Shadab Ahmad
 
Long-Term Durability of Transcatheter Aortic Valve Prostheses
Long-Term Durability of Transcatheter Aortic Valve ProsthesesLong-Term Durability of Transcatheter Aortic Valve Prostheses
Long-Term Durability of Transcatheter Aortic Valve Prostheses
Shadab Ahmad
 
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
Cardiac Troponin Elevation in Patients Without a Specific DiagnosisCardiac Troponin Elevation in Patients Without a Specific Diagnosis
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
Shadab Ahmad
 
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
Shadab Ahmad
 
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeAlirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Shadab Ahmad
 
Angiotensin neprilysin inhibition in acute decompensated heart failure
Angiotensin neprilysin inhibition in acute decompensated heart failureAngiotensin neprilysin inhibition in acute decompensated heart failure
Angiotensin neprilysin inhibition in acute decompensated heart failure
Shadab Ahmad
 
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical IllnessRivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Shadab Ahmad
 
A Study of Chest X-Ray PA View & Lateral Views
A Study of Chest X-Ray PA View & Lateral ViewsA Study of Chest X-Ray PA View & Lateral Views
A Study of Chest X-Ray PA View & Lateral Views
Shadab Ahmad
 
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
A No-Prophylaxis Platelet-Transfusion Strategyfor Hematologic CancersA No-Prophylaxis Platelet-Transfusion Strategyfor Hematologic Cancers
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
Shadab Ahmad
 
Probability of cancer in pulmonary nodules detected on first screening CT scan
Probability of cancer in pulmonary nodules detected on first screening CT scanProbability of cancer in pulmonary nodules detected on first screening CT scan
Probability of cancer in pulmonary nodules detected on first screening CT scan
Shadab Ahmad
 
Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Influence of the Timing of Malaria Infection during pregnancy on birth weight...Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Shadab Ahmad
 
Endocarditis in adults with bacterial meningitis
Endocarditis in adults with bacterial meningitisEndocarditis in adults with bacterial meningitis
Endocarditis in adults with bacterial meningitis
Shadab Ahmad
 

More from Shadab Ahmad (20)

Stemi
StemiStemi
Stemi
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Post pci management of acs
Post pci management of acsPost pci management of acs
Post pci management of acs
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Dis...
 
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Underg...
Residual Inflammatory Risk inPatients With Low LDL CholesterolLevels Underg...Residual Inflammatory Risk inPatients With Low LDL CholesterolLevels Underg...
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Underg...
 
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...
 
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricul...
 
Percutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve ReplacementPercutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve Replacement
 
Long-Term Durability of Transcatheter Aortic Valve Prostheses
Long-Term Durability of Transcatheter Aortic Valve ProsthesesLong-Term Durability of Transcatheter Aortic Valve Prostheses
Long-Term Durability of Transcatheter Aortic Valve Prostheses
 
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
Cardiac Troponin Elevation in Patients Without a Specific DiagnosisCardiac Troponin Elevation in Patients Without a Specific Diagnosis
Cardiac Troponin Elevation in Patients Without a Specific Diagnosis
 
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...His Resynchronization VersusBiventricular Pacing inPatients With Heart Fail...
His Resynchronization Versus Biventricular Pacing in Patients With Heart Fail...
 
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary SyndromeAlirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
 
Angiotensin neprilysin inhibition in acute decompensated heart failure
Angiotensin neprilysin inhibition in acute decompensated heart failureAngiotensin neprilysin inhibition in acute decompensated heart failure
Angiotensin neprilysin inhibition in acute decompensated heart failure
 
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical IllnessRivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
Rivaroxaban for thromboprophylaxis after Hospitalization for Medical Illness
 
A Study of Chest X-Ray PA View & Lateral Views
A Study of Chest X-Ray PA View & Lateral ViewsA Study of Chest X-Ray PA View & Lateral Views
A Study of Chest X-Ray PA View & Lateral Views
 
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
A No-Prophylaxis Platelet-Transfusion Strategyfor Hematologic CancersA No-Prophylaxis Platelet-Transfusion Strategyfor Hematologic Cancers
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
 
Probability of cancer in pulmonary nodules detected on first screening CT scan
Probability of cancer in pulmonary nodules detected on first screening CT scanProbability of cancer in pulmonary nodules detected on first screening CT scan
Probability of cancer in pulmonary nodules detected on first screening CT scan
 
Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Influence of the Timing of Malaria Infection during pregnancy on birth weight...Influence of the Timing of Malaria Infection during pregnancy on birth weight...
Influence of the Timing of Malaria Infection during pregnancy on birth weight...
 
Endocarditis in adults with bacterial meningitis
Endocarditis in adults with bacterial meningitisEndocarditis in adults with bacterial meningitis
Endocarditis in adults with bacterial meningitis
 

Recently uploaded

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 

Recent advances in diagnosis &amp; management of SLE

  • 1. Recent Advances in Diagnosis & Management of SLE Speaker- Dr. Shadab Ahmad
  • 2. Definition Systemic lupus erythematosus (SLE) is an autoimmune disease in which organs and cells undergo damage mediated by tissue binding autoantibodies and immune complexes. • 90 % of patients at diagnosis are women of childbearing age groups. • Highest prevalence is in black women and lowest is in white men.
  • 3. Risk factors • Female sex • Black ethnic groups • Exposure to UV light • Epstein-Barr virus (EBV) infection • Tobacco smoking • Prolonged occupational exposure to silica
  • 4. Female sex is permissive for SLE because • Hormone effects • Genes on X- chromosome • Epigenetic differences between genders • Estradiol binds to receptors on T and B lymphocytes, increasing activation and survival of those cells, thus favoring prolonged immune response. • So, women exposed to estrogen containing OCPs and hormone replacement therapy have an increased risk of developing SLE. • People with more X- chromosome (XXY karyotype, Klinefelter’s syndrome) have a significantly increased risk for SLE.
  • 6. Autoantibodies in SLE Antibodies Antigen Recognized ANA Multiple nuclear antigens Anti-dsDNA dsDNA Anti-Sm Protein complexed to 6 species of nuclear U1 RNA Anti-RNP Protein complexed to U1 RNA-gamma Anti-Ro (SS-A) Protein complexed to hY RNA (60 kDa, 52 kDa) Anti La (SS-B) Protein complexed to hY RNA (47 kDa) Anti-histone Histone associated with DNA(in nucleosome, chromatin) Antiphospholipid Phospholipids, beta-2 glycoprotein 1 cofactor, prothrombin Antierythrocyte Erythrocyte membrane Antiplatelet Surface and altered cytoplasmic antigens on platelets Antineuronal (anti-glutamate receptors) Neuronal and lymphocyte surface antigens Antiribosomal P Protein on ribosomes
  • 7. New Antibodies Antibodies Used as marker of Role in SLE Anti-nucleosome antibodies Disease activity and organ involvement Drug induced lupus, lupus nephritis, lupus flares Anti-C-1q antibodies Disease activity and organ involvement Nephritic flares NMDA receptor antibody Neuronal damage Neuropsychiatric disease Anti-Alpha actinin antibody Disease activity, renal involvement Lupus nephritis
  • 8. Diagnosis of SLE 1. ACR criteria 2. SLICC criteria
  • 9. ACR Criteria Malar rash Fixed erythema, flat or raised, over malar eminence Discoid rash Erythematous circular raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring may occur Photosensitivity Exposure to ultraviolet light causes rashes Oral ulcers Includes oral and nasopharyngeal ulcers, observed by physician Arthritis Nonerosive arthritis of two or more peripheral joints, with tenderness, swelling, or effusion Serositis Pleuritis or pericarditis documented by ECG or rub or evidence of effusion Renal disorder Proteinuria >0.5 g/d or 3+, or cellular casts Neurologic disorder Seizures or psychosis without other causes Hematologic disorders Hemolytic anemia or leukopenia (<4000/dl) or lymphopenia (<1500/dl) or thrombocytopenia (<1,00,000/dl) in absence of offendidng drugs Immunologic disorder Anti-dsDNA, anti-Sm, and/or anti-phospholipid Antinuclear antibodies An abnormal titer of ANA by immunofluorescence or an equivalent assay at any point in time in the absence of drugs known to induce ANAs Sensitivity is – 75% Specificity is – 95%
  • 10. SLICC criteria (Systemic Lupus International Collaborating Clinics Classification 2012 ) Clinical Criteria Acute Cutaneous lupus Lupus malar rash, bullous lupus, toxic epidermal necrolysis variant of SLE, maculopapular lupus rash, photosensitivity lupus rash (in absence of dermatomyositis) Chronic Cutaneous lupus Classic discoid rash localized (above the neck) or generalized (above and below neck), hypertrophic (verrucous) lupus, lupus panniculitis (profundus), mucosal lupus, chilblains lupus, discoid lupus/lichen planus overlap Oral Ulcers or Nasal Ulcers Oral: palate, buccal, tongue, nasal ulcers. In the absence of other causes, such as vasculitis, Behcet’s disease, infection, inflammatory bowel disease, reactive arthritis, and acidic foods Non-scarring alopecia Diffuse thinning or hair fragility with visible broken hairs, in the absence of other causes such as alopecia areata, drugs, iron deficiency, and androgenic alopecia Synovitis involving 2 or more joints Characterized by swelling or effusion or tenderness in 2 or more joints and at least 30 minutes of morning stiffness Serositis Typical pleurisy for more than 1 day or pleural effusion or pleural rub. Typical pericardial pain (pain with recumbency improved by sitting forward) for more than 1 day or pericardial effusion or pericardial rub or pericarditis by electrocardiography
  • 11. SLICC criteria cont… Clinical Criteria cont.. Renal Urine protein to creatinine ratio (or 24 hour urine protein) representing 500 mg protein/24 hour or red blood cell casts. Neurologic Seizure, psychosis, mononeuritis multiplex (in the absence of other known causes such primary vasculitis), myelitis, peripheral or cranial neuropathy (in the absence of other known causes such as primary vasculitis, infection, and diabetes mellitus), acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs) Hemolytic anemia Leukopenia (<4000/mm3) OR At least once: In the absence of other causes such as Felty’s syndrome, drugs, and portal hypertension Lymphopenia (<1000/mm3) At least once: In the absence of other known causes such as corticosteroids, drugs, and infection Thrombocytopenia (<100,000/mm3) At least once in the absence of other known causes such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura
  • 12. SLICC criteria cont… Immunologic Criteria ANA Level above laboratory reference range Anti-dsDNA Antibody level above laboratory reference range (or 2-fold if tested by ELISA) Anti-Sm Presence of antibody to Sm nuclear antigen Anti-phospholipid antibody Positivity, as determined by Positive test for lupus anticoagulant False-positive test result for rapid plasma regain Medium-or high titer anticardiolipin antibody level (IgA, IgG, or IgM) Positive test result for anti-2-glycoprotein I (IgA, IgG, or IgM) Low complement (C3, C4, or CH50) Direct Coomb’s test (In the absence of hemolytic anemia) Sensitivity is – 94% Specificity is – 92%
  • 13. Classify a patient as having SLE if.. ACR criteria  If ≥4 of these criteria, well documented, are present at any time in a patient’s history SLICC criteria  The patient satisfies four of the criteria including at least one clinical criterion and one immunologic criterion OR  The patient has biopsy proven nephritis compatible with SLE and with ANA or anti-dsDNA antibodies
  • 14. Novel Biomarkers in SLE Cellular markers Used as marker of Role in SLE CD27 plasma cells Disease activity Distinguish a lupus flare up from infection CD44v3/CD44v6-T cells Disease activity Lupus nephritis CD4- CD8- (double negative) t cells Disease activity Lupus nephritis Plasma MBL Disease activity Lupus nephritis (high level), Cutaneous lupus (low level) Complement activation products Diagnosis or disease activity Diagnosis of SLE Cytokines IFN-𝛼, IFN-𝛾 Disease activity/flare Marker and potential predictive marker for anti-type I IFN therapy MCP-1 Disease activity/flare IL-2, IL-6, IL-10, IL-17, IL-23 TNF-𝛼, IFN-𝛼, TGF-B Disease activity Diagnosis and progression of SLE TWEAK Disease activity Lupus nephritis
  • 15. Novel Biomarkers cont.. Genomic markers Used as marker of Role in SLE Fc receptor gene polymorphism Disease susceptibility Diagnosis of SLE DNA methylation markers (CD70, CD154, Perforin) Disease activity Diagnosis and monitoring Micro RNAs Disease activity and effect of treatment Monitoring of SLE New gene therapy strategies
  • 16. Therapeutic classification Mild Moderate Muco-cutaneous Butterfly rash Photosensitivity Maculopapular rash Mild oral ulcer Mild DLE Severe oral ulcer Severe DLE Diffuse SCLE Lupus profundus Skin vasculitis Articular Arthralgia Mild polyarthritis Disabiling polyarthritis
  • 17. Cont… Mild Moderate Severe Renal Class I,II Class III,IV LN Neuropsychiatry Lupus headache Chorea Peripheral neuropathy Delirium Encephalitis Psychosis Coma Myelopathy Hematological Platelet 30-100,000 Platelet 15-30,000 Hemolytic anemia Leucopenia Lupus adenitis Platelet <15,000
  • 18. Cont… Mild Moderate Severe Cardiopulmonary Pleurisy Pleural effusion Pneumonitis Pericarditis Mild myocarditis Severe pneumonitis with respiratory failure Pulmonary hemorrhage Cardiac temponade Severe myocarditis Gastro-intestinal Mild hepatitis Pancreatitis Peritonitis Severe hepatitis Colitis Protein losing enteropathy Mesenteric vasculitis Miscellaneous Responsive fever Fatigue Myalgia Refractory/high fever
  • 19. Treatment of SLE Conventional therapies • NSAIDs • Anti-malarials • Corticosteroids • Immunosupressants Targeted therapies • Monoclonal antibodies
  • 20. Drugs for management of SLE Medication Dose range Adverse effects NSAISs Upper limit of recommended range Aseptic meningitis, decreased renal function, vasculitis of skin, myocardial infarction, ototoxicity, GI irritation Topical glucocorticoids Mid potency for face High potency- other area Atrophy of skin, contact dermatitis, folliculitis, infection, hypopigmentation Topical sunscreens SPF 15 at least 30+ preferred Contact dermatitis Hydroxychloroquine 200-400 mg OD Retinal damage, agranulocytosis, thrombocytopenia, aplastic anemia, ataxia, cardiomyopathy, ototoxicity, neuropathy, seizures DHEA (dehydrepiandrosterone) 200 mg OD Acne, menstrual irregularity Methotrexate 10-25 mg once a week with folic acid Anemia, bone marrow suppression, leukopenia, infection, thrombocytopenia, hepatotoxicity, nephrotoxicity, neurotoxicity, pulmonary fibrosis, pneumonitis, teratogenic Oral glucocorticoids (Prednisone) 0.5-1 mg/kg/d- severe SLE 0.07-0.3 mg/kg/d- milder SLE Infection, hypertension, hyperglycemia, hypokalemia, aseptic necrosis of bone, cushingoid changes, osteoporosis, psychosis IV glucocorticoids (Methylprednisolone) 1 g *IV*OD for 3 days As oral glucocorticoids
  • 21. Cont… Medication Dose range Adverse effects Cyclophosphamide 7-25 mg/kg once a month for 6 months Infection, bone marrow suppression, leukopenia, anemia, thrombocytopenia, hemorrhagic cystitis, carcinoma bladder, alopecia, ovarian and testicular failure, teratogenic Mycophenolate mofetil 2-3 g/d Infection, leukopenia, anemia, thrombocytopenia, lymphoma, malignancy, alopecia, GI symptoms, hypertension, hypokalemia, tremor, teratogenic Azathioprine 2-3 mg/kg/d Infection, bone marrow suppression, leukopenia, anemia, thrombocytopenia, pancreatitis, hepatotoxicity, malignancy, alopecia, GI symptoms
  • 22. Targeted therapy in SLE Target Agent Role in SLE B Cell depletion Anti-CD20 Rituximab Effective in refractory SLE, no benefit in proliferative lupus nephritis Anti-CD22 Epratuzumab Reduction in corticosteroid dose in SLE Anti-CD11 Efalizumab Improvement in cutaneous SLE B Cell activation Anti-B Lys Antibody Belimumab Reduction in SLE activity, reduce flares Anti-B Lys+APRIL Atacicept Decrease in SLE autoantibodies B Cell tolerogens B cell tolerogen Abetimus, Edratide No long term benefit in lupus nephritis T-Cell target blockers Anti-CD40 antibodies Toralizumab Unproven role CTLA4-Ig Fusion protein Abatacept Improvement in non-life threatening SLE Cell surface receptor activation inhibition Sirolimus Role in refractory SLE
  • 23. Cont… Target Agent Role in SLE Cytokine inhibition Anti-TNF-𝛼 Infliximab Doubtful efficacy in lupus nephritis Anti-IFN-𝛼/-𝛾 Sifalimumab Rontalizumab No result released Anti-IL-1 Anakinra Improvement in SLE arthritis Anti-IL-6 Tocilizumab Clinical and serologic improvements in SLE Anti-IL-10 B-N10 Improvement in disease activity Other targets Anti-C5 monoclonal antibody Eculizumab Improvement in SLE Soluble recombinant complement C3 inhibitor sCR1 Improvement in disease activity Chemokine inhibitor Bindarit Improvement in disease activity
  • 24. Diagnosis & Initial therapy of SLE